Basic information Safety Supplier Related

METHYSERGIDE MALEATE

Basic information Safety Supplier Related

METHYSERGIDE MALEATE Basic information

Product Name:
METHYSERGIDE MALEATE
Synonyms:
  • 1-(hydroxymethyl)propylamideof1-methyl-(+)-lysergicacidhydrogenmaleate
  • deseril-retard
  • ergoline-8-beta-carboxamide,9,10-didehydro-n-(1-(hydroxymethyl)propyl)-1,6-dim
  • maleate(1:1)(salt)
  • Methysergide Maleate, USP
  • Methysergide Maleate (350 mg)
  • LWYXFDXUMVEZKS-ZVFOLQIPSA-N
  • methysergidebimaleate
CAS:
129-49-7
MF:
C25H31N3O6
MW:
469.54
EINECS:
204-950-9
Product Categories:
  • Antagonists
  • Neurotransmitters
  • Serotonergics
  • Serotonin receptor
  • ATRAVET
Mol File:
129-49-7.mol
More
Less

METHYSERGIDE MALEATE Chemical Properties

storage temp. 
Store at RT
solubility 
DMSO: >10 mg/mL
form 
solid
color 
white to off-white
Water Solubility 
Soluble to 10 mM in water with gentle warming
Stability:
Hygroscopic
More
Less

Safety Information

Hazard Codes 
T
Risk Statements 
25
Safety Statements 
45
RIDADR 
UN 2811 6.1/PG 3
WGK Germany 
3
RTECS 
KE5410000
HazardClass 
6.1(b)
PackingGroup 
III
HS Code 
2939690000
Toxicity
mouse,LD50,intravenous,185mg/kg (185mg/kg),"Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 101, 1972.

MSDS

More
Less

METHYSERGIDE MALEATE Usage And Synthesis

Description

Methysergide is an agonist of the serotonin (5-HT) receptor subtype 5-HT1 and an antagonist of 5-HT2 receptors. It binds to recombinant human 5-HT1A (KD = 23.44 nM), 5-HT1E (Ki = 229.09 nM), 5-HT1F (Ki = 33.88 nM), and rodent 5-HT1B receptors (KD = 1,513.56 nM). It also binds to recombinant human 5-HT2A (Ki = 2.69 nM) and 5-HT2C receptors (KD = 1.26 nM) and is an insurmountable antagonist at 5-HT2B receptors. It inhibits vasoconstriction induced by 5-HT in isolated postmortem human basilar arterial spiral strips (pA2 = 8.07). Methysergide decreases external carotid blood flow in a dose-dependent manner in vagosympathectomized dogs, an effect that is inhibited by the 5-HT1B/1D receptor antagonist GR127935 . It has antinociceptive activity in mouse models of pain induced by intrathecal injection of substance P , glutamate, NMDA , AMPA , or kainic acid. Methysergide reduces zymosan-induced paw edema in rats when administered at a dose of 10 mg/kg. Formulations containing methysergide were previously used in the prevention and treatment of vascular headaches.

Originator

Sansert ,Sandoz,US,1962

Uses

Methysergide maleate salt has been used as a serotonin (5HT) receptor antagonist to evaluate the potential systemic effects of methysergide (METH) and 5-HT infusions on production and milk composition in multiparous Holstein cows. It may also be used as a serotonin receptor blocker to identify the serotonergic receptor type involved in the direct excitation of mitral cells in the main olfactory bulb.

Uses

sedative

Definition

ChEBI: Methysergide maleate is an ergoline alkaloid.

Manufacturing Process

As described in US Patent 3,218,324, 0.9 part of potassium are dissolved in 500 parts by volume of liquid ammonia, then oxidized with ferric nitrate to potassium amide, after which 4.85 parts of lysergic acid-1'-hydroxybutylamide-2' are dissolved in the obtained mixture. After 15 minutes there are added to the obtained yellow solution 4.1 parts of methyl iodide in 5 parts by volume of ether, the mixture being allowed to stand for 30 more minutes at -60°C. The liquid ammonia is thereupon evaporated and the dry residue is shaken out between water and chloroform. The mixture of bases which remains after the evaporation of the chloroform is chromatographed on a column of 250 parts of aluminum oxide, the desired 1-methyl-lysergic acid-1'- hydroxy-butylamide-2' being washed into the filtrate with chloroform and chloroform-0.2% ethanol. The 1-methyl-lysergic acid-1'hydroxy-butylamide-2' crystallizes from chloroform in the form of plates which melt at 194° to 196°C. Reaction with maleic acid gives the dimaleate, melting at 187° to 188°C.

brand name

Sansert (Novartis).

Therapeutic Function

Migraine therapy

Biological Activity

Mixed 5-HT 1 /5-HT 2 receptor antagonist.

Biochem/physiol Actions

Methysergide maleate, also known as sansert, is a semisynthetic ergot alkaloid ergometrine derivative. Methysergide is a serotonin 1(5-HT1) receptor agonist and a nonselective 5-HT2 and 5-HT7 serotonin receptor antagonist. Methysergide maleate is used as a pharmacological agent to treat migraines and other vascular headaches. But, prolonged and uncontrolled use of this drug may cause Leriche′s syndrome, angina pectoris, acute ischemia of the limbs. In addition, gastrointestinal side effects, such as abdominal cramps, nausea, and diarrhea have also been observed in few patients.

Safety Profile

Poison by ingestion and intravenous routes. Experimental reproductive effects. Human mutation effects reported. When heated to decomposition it emits toxic fumes of NOx.

storage

Store at RT

METHYSERGIDE MALEATESupplier

3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
LGM Pharma
Tel
1-(800)-881-8210
Email
inquiries@lgmpharma.com
Spectrum Chemical Manufacturing Corp.
Tel
021-021-021-67601398-809-809-809 15221380277
Email
marketing_china@spectrumchemical.com
Shanghai TaoSu Biochemical Technology Co., Ltd.
Tel
021-33632979
Email
info@tsbiochem.com
Chizhou Kailong Import and Export Trade Co., Ltd.
Tel
Email
xg01_gj@163.com